Efficacy and safety of vibegron for treating overactive bladder: a prospective real-world study
Not Applicable
- Conditions
- overactive bladder
- Registration Number
- JPRN-UMIN000035771
- Lead Sponsor
- Department of Urology, Sapporo Medical University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 212
Inclusion Criteria
Not provided
Exclusion Criteria
the patient with allergy to beta 3 agonists
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of OABSS score after 8 weeks
- Secondary Outcome Measures
Name Time Method